Strategic Pharma Partnerships MDx offers GLP and cGMP analytical services for preclinical and clinical compounds, including PK/PD studies and biomarker discovery, positioning the lab as an outsourcing partner for pharma and mid-sized CROs seeking compliant, flexible analytical support.

Boutique Agility As a small team, MDx can deliver rapid turnarounds and highly customized service for pilot and early stage programs, enabling faster decision cycles and closer collaboration with emerging biotech companies.

Regional Market Access Located in College Station, TX, MDx can leverage proximity to Texas A&M and nearby biotech clusters to build regional partnerships with universities, startups, and grant-funded research programs.

Niche Analytical Expertise MDx’s capability to analyze both small and large molecules and perform biomarker discovery provides a differentiated, end to end offering that appeals to projects requiring method development, validation, and translational biomarker work.

Growth Through Partnerships With a scalable service model and a modern tech stack that supports secure communications and reporting, MDx can expand via channel partnerships, co-developed service packages, and enterprise grade reporting for larger sponsors.